IMOXI FOR DOGS- imidacloprid and moxidectin solution

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

IMIDACLOPRID (UNII: 3BN7M937V8) (IMIDACLOPRID - UNII:3BN7M937V8), MOXIDECTIN (UNII: NGU5H31YO9) (MOXIDECTIN - UNII:NGU5H31YO9)

Available from:

Vetoquinol USA, Inc.

Administration route:

TOPICAL

Prescription type:

PRESCRIPTION

Therapeutic indications:

ACPX1008 Once-a-month topical solution for the prevention of heartworm disease, the treatment of circulating microfilariae, kills adult fleas, is indicated for the treatment of flea infestations, the treatment and control of sarcoptic mange, as well as the treatment and control of intestinal parasite infections in dogs and puppies that are at least 7 weeks of age and that weigh at least 3 lbs. IMOXI™ Topical Solution for Dogs is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and the treatment of Dirofilaria immitis circulating microfilariae in heartworm-positive dogs. IMOXI™ Topical Solution for Dogs kills adult fleas and is indicated for the treatment of flea infestations (Ctenocephalides felis ). IMOXI™ Topical Solution for Dogs is indicated for the treatment and control of sarcoptic mange caused by Sarcoptes scabiei var. canis . IMOXI™ Topical Solution for Dogs is also indicated for the treatment and control of the following intestinal parasites: Do not administer this p

Authorization status:

Abbreviated New Animal Drug Application

Summary of Product characteristics

IMOXI FOR DOGS- IMIDACLOPRID AND MOXIDECTIN SOLUTION
VETOQUINOL USA, INC.
----------
IMOXI™ TOPICAL SOLUTION FOR DOGS
(IMIDACLOPRID + MOXIDECTIN)
ACPX1008
ONCE-A-MONTH TOPICAL SOLUTION FOR THE PREVENTION OF HEARTWORM DISEASE,
THE
TREATMENT OF CIRCULATING MICROFILARIAE, KILLS ADULT FLEAS, IS
INDICATED FOR THE
TREATMENT OF FLEA INFESTATIONS, THE TREATMENT AND CONTROL OF SARCOPTIC
MANGE, AS WELL AS THE TREATMENT AND CONTROL OF INTESTINAL PARASITE
INFECTIONS
IN DOGS AND PUPPIES THAT ARE AT LEAST 7 WEEKS OF AGE AND THAT WEIGH AT
LEAST
3 LBS.
WARNING
DO NOT ADMINISTER THIS PRODUCT ORALLY
FOR THE FIRST 30 MINUTES AFTER APPLICATION ENSURE THAT DOGS CANNOT
LICK
THE PRODUCT FROM APPLICATION SITES ON THEMSELVES OR OTHER TREATED
ANIMALS.
CHILDREN SHOULD NOT COME IN CONTACT WITH APPLICATION SITES FOR TWO (2)
HOURS AFTER APPLICATION.
(SEE CONTRAINDICATIONS, WARNINGS, HUMAN WARNINGS, AND ADVERSE
REACTIONS, FOR MORE INFORMATION.)
CAUTION:
Federal (USA) Law restricts this drug to use by or on the order of a
licensed
veterinarian.
DESCRIPTION:
IMOXI™ Topical Solution for Dogs (10% imidacloprid + 2.5%
moxidectin) is a colorless to
yellow ready-to-use solution packaged in single dose applicator tubes
for topical
treatment of dogs. The formulation and dosage schedule are designed to
provide a
minimum of 4.5 mg/lb. (10 mg/kg) imidacloprid and 1.1 mg/lb. (2.5
mg/kg) moxidectin
based on body weight.
Imidacloprid is a chloronicotinyl nitroguanidine insecticide. The
chemical name for
imidacloprid is 1- [(6-Chloro- 3-pyridinyl)
methyl]-N-nitro-2-imidazolidinimine. Moxidectin
is a semisynthetic macrocyclic lactone endectocide derived from the
actinomycete
_Streptomycetes cyaneogriseus noncyanogenus_. The chemical name for
moxidectin is
[6R, 23E, 25S(E)]-5-O-Demethyl-28-deoxy- 25-(1,3-dimethl-1-
butenyl)-6,28-epoxy-23-
(methoxyimino) milbemycin B.
INDICATIONS:
IMOXI™ Topical Solution for Dogs is indicated for the prevention of
heartworm disease
caused by _Dirofilaria immitis_ and the treatment of _Dirofilaria
immitis_ circulating
micro